Company / R&D Expense
Outset Medical, Inc. R&D Expense History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D Expense
$57.3M
FY2025
5-year range
$23.3M / $57.3M
FY2021-FY2025
Trend
+17.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
R&D Expense has increased for 5 consecutive years, from $23M in FY2020 to $57M in FY2025.
Based on SEC 10-K filings.
$57M in FY2025 with a 5-year CAGR of +20.1%.
Improved from $37M to $57M over the past 2 years.
R&D Expense over time
Growth rates
- 3-Year CAGR
- +25.7%
- 5-Year CAGR
- +20.1%
- 10-Year CAGR
- -
Key checks
Key Insights
- Outset Medical, Inc.'s r&d expense has grown for 5 consecutive years.
- 5-year CAGR of +20.1%, indicating consistent growth.
- In FY2025, r&d expense increased 17.3% year-over-year.
- Lowest r&d expense in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score -0.88 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $57.3M | +17.3% |
| FY2024 | $48.9M | +33.0% |
| FY2023 | $36.7M | +27.4% |
| FY2022 | $28.9M | +23.7% |
| FY2021 | $23.3M | +1.8% |
| FY2020 | $22.9M | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026